Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments

A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat metastatic breast cancer in humans, UTHealth Houston researchers have discovered. The research was published in Molecular Therapy Oncology and led b